DG
34
4
AAL
50
2
LYB
39
-7
CRM
59
4
BSX
73
2
MCD
50
3
STI
20
-23
GE
65
4
HP
32
-2
CB
48
-3
UHS
66
2
KMB
37
-3
EBAY
47
2
PFE
40
3
WY
37
-2
NUE
44
3
EA
49
3
PDCO
49
3
HBAN
57
3
WDC
57
3
DG
34
4
AAL
50
2
LYB
39
-7
CRM
59
4
BSX
73
2
MCD
50
3
STI
20
-23
GE
65
4
HP
32
-2
CB
48
-3
UHS
66
2
KMB
37
-3
EBAY
47
2
PFE
40
3
WY
37
-2
NUE
44
3
EA
49
3
PDCO
49
3
HBAN
57
3
WDC
57
3
Financhill
Back

Supernus Pharmaceuticals Vs. Pacira BioSciences Industry Stock Comparison

Sell
31

SUPN
Supernus Pharmaceuticals

Last Price:
29.25
Seasonality Move:
14.18%
Buy
56

PCRX
Pacira BioSciences

Last Price:
31.52
Seasonality Move:
7.59%
Sell
31
Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals a Buy, Sell or Hold?

  • The current Supernus Pharmaceuticals [SUPN] share price is $28.74. The Score for SUPN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Pacira BioSciences (PCRX) is a Buy

Is Pacira BioSciences a Buy, Sell or Hold?

  • The current Pacira BioSciences [PCRX] share price is $30.08. The Score for PCRX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • PCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SUPN Stock Price Chart

What is Supernus Pharmaceuticals's stock price today?

  • The Supernus Pharmaceuticals share price today is $28.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.

PCRX Stock Price Chart

What is Pacira BioSciences's stock price today?

  • The Pacira BioSciences share price today is $30.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.

SUPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 39.72 Sell
Chaikin Money Flow: -306562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.18 - 30.78) Sell
Bollinger Bands (100): (27.87 - 32.19) Sell

PCRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.63 Buy
Relative Strength Index (14 RSI): 61.97 Buy
Chaikin Money Flow: -624096 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.81 - 28.95) Buy
Bollinger Bands (100): (27.58 - 32.18) Buy

SUPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.91 Sell
20-day SMA: 29.94 Sell
50-day SMA: 31.56 Sell
200-day SMA: 29.07 Sell
8-day EMA: 29.58 Sell
20-day EMA: 30.1 Sell
50-day EMA: 30.5 Sell
200-day EMA: 30.2 Sell

PCRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.15 Buy
20-day SMA: 27.5 Buy
50-day SMA: 28.36 Buy
200-day SMA: 30.78 Sell
8-day EMA: 29.37 Buy
20-day EMA: 28.34 Buy
50-day EMA: 28.41 Buy
200-day EMA: 31.57 Sell

Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.19 per share, and an increase next year of $0.58 per share.

Pacira BioSciences Earnings Growth & PCRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.14 per share, and an increase next year of $0.80 per share.

Supernus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pacira BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):